In 1902, Bayliss and Starling proposed that intestinal mucosa contains a hormone that stimulates the exocrine secretion of the pancreas (secretin)
These findings underscore albiglutides potential as an effective adjunct therapy for glycemic control and cardiovascular risk reduction in T2DM management
Benefits of Retatrutide (Reta) Significant and Sustained Weight Loss Retatrutide has shown exceptional results in clinical studies, offering some of the most substantial weight-loss outcomes seen in modern metabolic medicine
Lee MMY, Ghouri N, McGuire DK, Rutter MK, Sattar N
Danuglipron reduced HbA1c by 1.04% to 1.57% and weight by 1.93 kg to 5.38 kg
Glucagon receptor: Increases energy use and fat breakdown, supporting weight loss through higher calorie burning